PARP1 and astrocytoma (excluding glioblastoma): Our findings underline that PARP1 is a marker candidate of higher-grade in astrocytomas, presumably because higher PARP1 expression facilitates the repair of damaged DNA and, thereby, overcomes the genetic instability characteristics of tumour cells [27].